ExploreWatchlistsPricing
  1. JP-listed companies
  2. CanBas Co.,Ltd.
  3. Financials
  4. Stockholders' equity

CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Jun 30, 20252,944+25.76%
Jun 30, 20242,341+21.15%
Jun 30, 20231,932+670.74%
Jun 30, 2022251-42.76%
Jun 30, 2021438+84.87%
Jun 30, 2020237-63.90%
Jun 30, 2019656+55.54%
Jun 30, 2018422-54.49%
Jun 30, 2017927-0.22%
Jun 30, 2016929-3.69%
Jun 30, 2015965+188.28%
Jun 30, 2014335-47.29%
Jun 30, 2013635

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat